pyrazines has been researched along with Fever in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epstein, C; Hayden, FG; Kang, LL; Lenk, RP; Oldham-Creamer, C; Stonis, L | 1 |
| Gao, M; Hu, J; Li, Q; Nie, C; Qian, H; Qiao, Y; Qiao, Z; Wang, Q; Wang, Y; Yan, L | 1 |
| Alper, S; Altuğ, E; Çelebi, İ; Demirkesen, C; Ferhanoğlu, B; Kocatürk, E; Taşkın, B; Vural, S | 1 |
| Abe, S; Fujimori, D; Kaizuka, H; Otsuki, S; Takeuchi, Y; Takoi, H; Togashi, Y; Wada, T | 1 |
| Hase, R; Ishida, K; Kurita, T; Mito, H; Muranaka, E; Sasazawa, H; Yano, Y | 1 |
| Igari, H; Ikusaka, M; Kasai, H; Sakao, S; Shimada, R; Takayanagi, S; Taniguchi, T; Tawara, J; Uehara, T; Yahaba, M | 1 |
| Fukui, Y; Kaneda, M; Kawago, K; Kawasuji, H; Kimoto, K; Miyajima, Y; Morinaga, Y; Murai, Y; Ogami, C; Sakamaki, I; Takegoshi, Y; Tsuji, Y; Ueno, A; Yamamoto, Y | 1 |
| Arima, N; Baba, M; Okamoto, M; Saijo, M; Sakakibara, N; Toyama, M | 1 |
| Bethel, LM; Caroline, AL; Hartman, AL; Oury, TD; Powell, DS; Reed, DS | 1 |
| Aizawa, S; Heike, Y; Kim, SW; Kobayashi, Y; Maruyama, D; Nagase, K; Takahashi, N; Tobinai, K; Waki, F; Watanabe, T; Yamasaki, S; Yokoyama, H | 1 |
| Alimena, G; Breccia, M; Cilloni, D; D'Auria, F; Gottardi, E; Latagliata, R; Mandelli, F; Musto, P; Saglio, G; Sanpaolo, G | 1 |
| Dumitrescu, O; Gerecitano, J; Hamlin, P; Horanlli, E; Iasonos, A; Mo, Q; Moskowitz, CH; Noy, A; O'Connor, OA; Pappanicholaou, J; Portlock, C; Rojas, CN; Sarasohn, D; Schulman, P; Straus, D; Zelenetz, AD; Zhang, Z | 1 |
| Heule, F; Lam, K; Sonneveld, P; Wu, KL | 1 |
| Gudelsky, GA; Koenig, JI; Meltzer, HY | 1 |
3 trial(s) available for pyrazines and Fever
| Article | Year |
|---|---|
Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
Topics: Adult; Antiviral Agents; Double-Blind Method; Fever; Humans; Influenza, Human; Pyrazines; RNA; Treatment Outcome | 2022 |
Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Boronic Acids; Bortezomib; Diarrhea; Drug Administration Schedule; Erythroid Cells; Female; Fever; Gene Expression; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Thrombocytopenia; Treatment Outcome; WT1 Proteins | 2011 |
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Diarrhea; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Fever; Follow-Up Studies; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Pyrazines; Recurrence; Rituximab; Treatment Outcome | 2011 |
11 other study(ies) available for pyrazines and Fever
| Article | Year |
|---|---|
Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Fever; Humans; Models, Molecular; Molecular Structure; Pyrazines; Pyridines; Rats; Structure-Activity Relationship; TRPV Cation Channels | 2020 |
Coronavirus 19 presenting with atypical Sweet's syndrome.
Topics: Amides; Antibodies, Monoclonal, Humanized; Biopsy, Needle; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Erythema; Facial Dermatoses; Female; Fever; Humans; Immunohistochemistry; Middle Aged; Pandemics; Pneumonia, Viral; Pyrazines; Real-Time Polymerase Chain Reaction; Sweet Syndrome; Tomography, X-Ray Computed | 2020 |
Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
Topics: Adult; Amides; Antiviral Agents; Body Temperature; COVID-19; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Male; Pyrazines; SARS-CoV-2; Treatment Outcome | 2020 |
A Favipiravir-induced Fever in a Patient with COVID-19.
Topics: Aged, 80 and over; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Fever; Humans; Male; Pandemics; Pneumonia, Viral; Pyrazines; SARS-CoV-2 | 2020 |
Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient.
Topics: Amides; Antiviral Agents; COVID-19; Fever; Humans; Male; Middle Aged; Pharmaceutical Preparations; Pyrazines; SARS-CoV-2 | 2021 |
A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test.
Topics: Amides; COVID-19; COVID-19 Drug Treatment; Female; Fever; Humans; Lymphocyte Activation; Middle Aged; Pyrazines; Viral Load | 2021 |
Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.
Topics: Amides; Amodiaquine; Animals; Antiviral Agents; Bunyaviridae; Bunyaviridae Infections; Cell Line; Chlorocebus aethiops; Fever; Humans; Microbial Sensitivity Tests; Pyrazines; Ribavirin; Thrombocytopenia; Virus Replication | 2017 |
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever.
Topics: Amides; Animals; Antiviral Agents; Chemoprevention; Female; Fever; Pyrazines; Rats; Rats, Inbred WF; Rift Valley Fever; Survival Analysis; Treatment Outcome; Weight Loss | 2014 |
Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Cells; Boronic Acids; Bortezomib; Cell Line, Tumor; Cytokines; Female; Fever; Humans; Inflammation Mediators; Male; Middle Aged; Multiple Myeloma; Pyrazines; Stromal Cells | 2008 |
Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma.
Topics: Adult; Aged; Boronic Acids; Bortezomib; Drug Eruptions; Drug Therapy, Combination; Erythema; Fever; Glucocorticoids; Histamine H1 Antagonists; Humans; Male; Medical Records; Middle Aged; Multiple Myeloma; Prednisone; Protease Inhibitors; Pyrazines; Skin; Skin Ulcer | 2006 |
Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Dose-Response Relationship, Drug; Fever; Male; Mianserin; Pyrazines; Rats; Receptors, Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1987 |